Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy
Globoid cell leukodystrophy (GLD) is a demyelinating lysosomal storage disease due to the deficiency of the galactocerebrosidase (GALC) enzyme. The favorable outcome of hematopoietic stem and progenitor cell (HSPC)-based approaches in GLD and other similar diseases suggests HSPC gene therapy as a pr...
Main Authors: | Silvia Ungari, Annita Montepeloso, Francesco Morena, Fabienne Cocchiarella, Alessandra Recchia, Sabata Martino, Bernhard Gentner, Luigi Naldini, Alessandra Biffi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S232905011630050X |
Similar Items
-
CNS-targeted Gene Therapy in Globoid Cell Leukodystrophy
by: Dar-Shong Lin, et al.
Published: (2013) -
Ex vivo gene therapy approaches for the treatment of globoid cell leukodystrophy
by: Visigalli, Ilaria
Published: (2009) -
Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture
by: Jacqueline A. Hawkins-Salsbury, et al.
Published: (2013-12-01) -
Globoid cell leukodystrophy (Krabbe's disease): isolation of myelin with normal glycolipid composition
by: YOSHIKATSU ETO, et al.
Published: (1970-09-01) -
Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy
by: Adarsh S. Reddy, et al.
Published: (2012-01-01)